WestEnd Advisors’s GE HealthCare GEHC Stock Holding History

WestEnd Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$832	Buy	13 +1	+8%	+$66	﹤0.01%	298
2026 Q1	$854	Hold	12	–	–	﹤0.01%	253
2025 Q4	$984	Sell	12 -1	-8%	-$78	﹤0.01%	238
2025 Q3	$976	Sell	13 -6	-32%	-$448	﹤0.01%	234
2025 Q2	$1.41K	Buy	19 +1	+6%	+$70	﹤0.01%	186
2025 Q1	$1.45K	Buy	18 +12	+200%	+$1.03K	﹤0.01%	178
2024 Q4	$469	Buy	6 +1	+20%	+$85	﹤0.01%	182
2024 Q3	$469	Hold	5	–	–	﹤0.01%	179
2024 Q2	$390	Sell	5 -1	-17%	-$82	﹤0.01%	182
2024 Q1	$545	Hold	6	–	–	﹤0.01%	146
2023 Q4	$464	Buy	6 +1	+20%	+$70	﹤0.01%	162
2023 Q3	$340	Buy	+5	New	+$364	﹤0.01%	183
2023 Q1	–	Hold	0	–	–	–	169

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

WestEnd Advisors's GEHC Position: Q2 2026 in Review

WestEnd Advisors increased its GE HealthCare (GEHC) stake by 8.3% in Q2 2026, buying an estimated $66 and bringing the position to 13 shares worth $832. The position accounts for ﹤0.01% of the portfolio, ranked #298.

WestEnd Advisors first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.45K in Q1 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

WestEnd Advisors held 13 shares of GE HealthCare worth $832 as of Q2 2026.
WestEnd Advisors bought 1 GE HealthCare share in Q2 2026, an estimated $66.
GE HealthCare made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #298 holding.
WestEnd Advisors first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
WestEnd Advisors's GE HealthCare position peaked at $1.45K in Q1 2025.
1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.